Vertex Pharmaceuticals (VRTX) Share-based Compensation Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.18% |
| Dec 31, 2025 | -6.08% |
| Sep 30, 2025 | 5.58% |
| Jun 30, 2025 | 8.50% |
| Mar 31, 2025 | -13.44% |
| Dec 31, 2024 | -19.56% |
| Sep 30, 2024 | 41.02% |
| Jun 30, 2024 | 29.25% |
| Mar 31, 2024 | 56.78% |
| Dec 31, 2023 | 87.09% |
| Sep 30, 2023 | -3.47% |
| Jun 30, 2023 | 4.74% |
| Mar 31, 2023 | -6.06% |
| Dec 31, 2022 | -5.99% |
| Sep 30, 2022 | 31.65% |
| Jun 30, 2022 | 8.89% |
| Mar 31, 2022 | 13.11% |
| Dec 31, 2021 | 22.18% |
| Sep 30, 2021 | 3.48% |
| Jun 30, 2021 | -10.74% |
| Mar 31, 2021 | -0.44% |
| Dec 31, 2020 | 5.96% |
| Sep 30, 2020 | 16.53% |
| Jun 30, 2020 | 30.66% |
| Mar 31, 2020 | 23.37% |
| Dec 31, 2019 | 16.04% |
| Sep 30, 2019 | -0.13% |
| Jun 30, 2019 | 8.80% |
| Mar 31, 2019 | 20.04% |
| Dec 31, 2018 | 3.54% |
| Sep 30, 2018 | 14.88% |
| Jun 30, 2018 | 12.78% |
| Mar 31, 2018 | 12.52% |
| Dec 31, 2017 | 22.98% |
| Sep 30, 2017 | 21.64% |
| Jun 30, 2017 | 18.01% |
| Mar 31, 2017 | 25.18% |
| Dec 31, 2016 | 38.87% |
| Sep 30, 2016 | -6.88% |
| Jun 30, 2016 | -2.09% |
| Mar 31, 2016 | -3.33% |
| Dec 31, 2015 | 5.34% |
| Sep 30, 2015 | 338.08% |
| Jun 30, 2015 | 49.05% |
| Mar 31, 2015 | 23.19% |
| Dec 31, 2014 | 81.35% |
| Sep 30, 2014 | -21.67% |
| Jun 30, 2014 | 2.65% |
| Mar 31, 2014 | 48.94% |
| Dec 31, 2013 | -15.44% |
| Sep 30, 2013 | -30.55% |
| Jun 30, 2013 | 31.78% |
| Mar 31, 2013 | 12.96% |
| Dec 31, 2012 | -4.88% |
| Sep 30, 2012 | -6.23% |
| Mar 31, 2012 | -0.69% |
| Dec 31, 2011 | 23.25% |
| Sep 30, 2011 | 23.75% |
| Mar 31, 2011 | 44.20% |
| Dec 31, 2010 | 32.99% |
| Sep 30, 2010 | 18.05% |
| Jun 30, 2010 | -8.03% |
| Mar 31, 2010 | -13.22% |